Product Catalog
HOME / BRACHYTHERAPY SOLUTIONS / PRODUCTS / SEEDS / THERASEED® – PD-103
Palladium-103
Setting the standard in Palladium seed technology
Backed by Theragenics’ trusted quality and expertise and supported by more than 35 years of clinical use, TheraSeed® PD-103 is globally recognized as the industry standard for Palladium seed technology.
* Seed not to scale – TheraSeed is 4.5mm long x 0.8mm high
Exclusive design
- Distinctive concave end cups designed to facilitate tissue fixity
- Laser welded titanium capsule containing two Pd-103 plated graphite pellets and a lead x-ray marker
- Available in a wide range of activities with both standard and high activity options
Unrivaled clinical experience
- Pd-103 shorter half-life and lower energy photons provide distinct radiobiologic advantages over I-125, and may achieve greater disease control over I-1251
- Pd-103 implants demonstrate greater dose heterogeneity, which is associated with improved oncologic outcomes1
Trusted quality
- Pd-103 produced on our own cyclotrons and seeds manufactured in Buford, GA
- Dosimetric characterization of TheraSeed® Pd-103 include Monte Carlo and experimental studies conducted in accordance with the AAPM Task Group 43 update (TG43U2)2
TheraSeed® can be supplied in a range of brachytherapy devices and delivery methods
We offer a comprehensive portfolio of strands, preloaded needles, and carriers, as well as Fiducial Markers – all supported by our personalized customer service. Because we are dedicated to providing effective, minimally invasive treatment options with minimal side effects, we continue to invest in this field.
Preloaded Brachytherapy Needle Trays
Configurations & Carriers
ANCHORSEED Bio-absorbable polymer seed
Configurations & Carriers
C20 Brachytherapy
Seed Cartridges
Configurations & Carriers
Brachytherapy Stranded Seeds
Configurations & Carriers
Seed Carrier
(Eye Plaque)
Configurations & Carriers
Gold Fiducial
Markers
Fiducial Markers
AnchorMarker
Fiducial Markers
- Configurations & Carriers
- PreLoaded Needle Trays
- Seed Cartridges
- Strands
- Intra-Ocular Carriers
- Fiducial Markers
TheraSeed® - Palladium-103
TheraSeed® Pd-103 is indicated for the treatment of localized and unresectable tumors with low to moderate radiosensitivity. Tumors may be recurrent or residual following external beam radiation or excision of primary tumor.
Interested in learning more?
Backed by Theragenics trusted quality and expertise and supported by more than 35 years of clinical use, TheraSeed® PD-103 is globally recognized as the industry standard for Palladium seed technology.
- Unrivaled clinical experience
- Trusted quality
- Exclusive design
Backed by Theragenics trusted quality and expertise and supported by more than 35 years of clinical use, TheraSeed® PD-103 is globally recognized as the industry standard for Palladium seed technology.
- Unrivaled clinical experience
- Trusted quality
- Exclusive design
Backed by Theragenics trusted quality and expertise and supported by more than 35 years of clinical use, TheraSeed® PD-103 is globally recognized as the industry standard for Palladium seed technology.
- Unrivaled clinical experience
- Trusted quality
- Exclusive design
See why partnering with Theragenics
is the right choice for you and your patients
Personalized Service for a Personalized Cancer Treatment
Personalized Service for a Personalized Cancer Treatment
A Commitment to the Future of Brachytherapy
A Commitment to the Future of Brachytherapy
Local Sourcing & Manufacturing for Greater Scale
Local Sourcing & Manufacturing for Greater Scale
Strategic Location and Logistics Expertise
Strategic Location and Logistics Expertise
Regulatory Compliance and Quality Assurance
Regulatory Compliance and Quality Assurance
- Tang, et. al., “Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: an international, multi-institutional study”, Radiotherapy and Oncology, Volume 183, June 2023, 109599.
- Rivard, et al., “Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations”, Med Phys. 31, 663-674, (2004)
TheraSeed® Pd-103 source and accessories should be used by physicians who are qualified by training and experience in the safe use and handling of radionuclide brachytherapy sources and whose experience and training has been approved by the appropriate government authorities authorized to license the use of radioactive materials.
Information intended for the USA. Indications may vary in different countries; please either consult the appropriate IFU or your local distributor.
Related Products
AgX100®
Iodine-125 Seeds
Brachytherapy Seeds
Cesium-131
Seeds
Brachytherapy Seeds
Gold Fiducial
Markers
Fiducial Markers
AnchorMarker
Fiducial Markers
AgX100® - Iodine-125
AgX100® - Iodine-125
Shaping a better future for cancer patients
For more than 40 years, Theragenics has been manufacting and delivering Brachytherapy products and solutions with unmatched expertise, and a proven track record of success – all from our world-class facility just outside Atlanta GA. We continue our mission of advancing brachytherapy and to deliver effective cancer treatments that offer hope to patients worldwide.